Exchange: NASDAQ·Updated 06:42 PM EST

CNTX News

News
all
press releases
New Strong Sell Stocks for October 15th
CDZI, CNSY and CNTX have been added to the Zacks Rank #5 (Strong Sell) List on October 15, 2026.
Zacks
New Strong Sell Stocks for October 15th
CDZI, CNSY and CNTX have been added to the Zacks Rank #5 (Strong Sell) List on October 15, 2026.
Zacks
More News
ATS, CANG and CNTX have been added to the Zacks Rank #5 (Strong Sell) List on October 13, 2026.
Zacks
Maxim Says Context Therapeutics (CNTX)'s Share Pullback Is an Overreaction; Remains Bullish...
Yahoo! Finance: News
The Philadelphia biotech reported data from 21 patients with advanced CLDN6-positive solid tumors, including 14 with platinum-resistant ovarian cancer.
Stocktwits
Context Therapeutics (NASDAQ:CNTX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.03...
MarketBeat
Context Therapeutics (NASDAQ:CNTX) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
Context Therapeutics (NASDAQ:CNTX) Shares Down 7% - Here's What Happened...
MarketBeat
Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced the appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary. Ms. Stacey is an accomplished chief legal and compliance officer and board secretary with extensive...
Business Wire
Wall Street Zen downgraded Context Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat
Context Therapeutics Inc. (NASDAQ:CNTX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine research firms that are currently covering the stock, MarketBeat...
MarketBeat

Advertisement|Remove ads.